1st shipment of Medicine for SMA patients arrives in Iran

TEHRAN, Aug. 02 (MNA) – Head of Iranian Food and Drug Administration (IFDA) on Tuesday announced the arrival of first shipment of medicines for patients suffering from Spinal Muscular Atrophy (SMA) disease into the country.

Dr. Bahram Daraei made the remarks on Tuesday and added, “Following the order of Iranian President Ebrahim Raeisi on the need to provide medicines for SMA patients, the Iranian Food and Drug Administration took necessary measures in this regard in order to quickly supply of two items of medicine for these patients.”

Accordingly, “Spinraza”, as the first medicine provided for SMA patients, has been imported into the country and will soon be supplied and made available to these patients in cooperation and collaboration with the Ministry of Health and Medical Education, he added.


News Code 189789


Your Comment

You are replying to: .
  • captcha